Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Description

Dr. Adam Striker and Dr. Aaron Primm, editor for Summaries of Emerging Evidence (SEE), discuss recent studies included in the 40B issue of SEE that add to our understanding of ketamine. Learn how ketamine compares to electroconvulsive therapy (ECT) for the treatment of chronic depression and how intranasal ketamine might be used to treat refractory chronic migraines (https://www.asahq.org/see). Recorded July 2024.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.